购物车
- 全部删除
- 您的购物车当前为空
Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1].
Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1].
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1]. |
体外活性 | Anticancer agent 74 has low cytotoxicity in HepG2 (IC 50 : 72.27 μM), A549 (IC 50 : 70.79 μM), HuCCA-1 (IC 50 : 70.42 μM) and MOLT-3 (IC 50 : 20.71 μM) cell lines. Anticancer agent 74 has low selectivity in HepG2 (IC 50 : 0.88 μM), A549 (IC 50 : 5.08 μM), HuCCA-1 (IC 50 : 5.11 μM) and MOLT-3 (IC 50 : 17.39 μM) cell lines [1]. Cell Cytotoxicity Assay Cell Line: A549, HuCCA-1, HepG2 and MOLT-3 cell lines Concentration: Incubation Time: Result: Had good cytotoxicity, low selectivity and cytotoxicity in all four primary cancer cell lines. |
分子量 | 351.44 |
分子式 | C25H21NO |
CAS No. | 2242503-82-6 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容